- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/74 - Major histocompatibility complex [MHC]
Patent holdings for IPC class C07K 14/74
Total number of patents in this class: 2073
10-year publication summary
|
105
|
124
|
189
|
250
|
250
|
299
|
262
|
217
|
171
|
75
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1127 |
522 |
| Cue Biopharma, Inc. | 206 |
108 |
| Regeneron Pharmaceuticals, Inc. | 4701 |
66 |
| CRISPR Therapeutics AG | 367 |
54 |
| University Health Network | 1061 |
38 |
| 10X Genomics, Inc. | 1382 |
23 |
| Universite de Montreal | 349 |
22 |
| The Regents of the University of California | 20745 |
20 |
| Board of Regents, The University of Texas System | 6107 |
20 |
| Sana Biotechnology, Inc. | 178 |
16 |
| Ecole Polytechnique Federale de Lausanne (epfl) | 1609 |
14 |
| Imcyse SA | 60 |
14 |
| Oregon Health & Science University | 754 |
14 |
| Sangamo Therapeutics, Inc. | 383 |
13 |
| Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 270 |
13 |
| Dana-Farber Cancer Institute, Inc. | 2664 |
12 |
| UTi Limited Partnership | 461 |
12 |
| Xyphos Biosciences Inc. | 35 |
12 |
| Massachusetts Institute of Technology | 10251 |
10 |
| President and Fellows of Harvard College | 6094 |
10 |
| Other owners | 1060 |